Earlier this year, a strategic partnership agreement was signed between Compass Ventures Group and TusHolding that focused on collaboration in advanced technology projects that include the creation of mutual investment funds, innovation platforms and high-tech science parks. Compass Ventures, a key strategic partner in both the Israeli and Chinese markets joined the Tus team in Israel, to identify and partner on addressing the latest innovative opportunities in the Israeli market.
The Compass Ventures delegation was led by Dr. Ronen Dagon, Chairman of Compass Ventures, Mr. Moshe Kamar, CEO of Compass Ventures, and Dr. Mira Peled, Compass Advisory Board member and former founder and CEO of Applied Immune Technology, a leading biotech company. The Tus delegation was led by the President of Tus. Together, the Compass-Tus delegation met with over 20 different leading Israeli technology companies. Each company focused on a different sector that ranged from security, IoT, smart city, safe city, pharmaceutical, automotive to additional sectors. The delegation also explored key R&D centers, while visiting Israel’s leading science and technology institutions such as the Technion, Israel’s Institute of Technology, and the University of Tel-Aviv.
During the delegation, Dr. Ronen Dagon, Chairman of Compass Ventures, shared his personal experience in the Chinese market, he spoke on Compass’s strong collaboration with Tus for over10 years, and encouraged Israeli technology-driven companies to prepare for additional collaboration with their Chinese counterparts.
Mr. Moshe Kamar, Compass’s CEO, noted Israel’s tech savvy spirit and mentioned that the Israeli landscape, with its broad range of technologies across a large scope of sectors, has the potential of improving and revolutionizing technologies, which would in turn make the world a better and safer place.